Mutation analysis of the HIF-1α oxygen-dependent degradation domain in invasive breast cancer
Authors:
- Astrid E. GreijerAGAstrid E. Greijer
- Elsken van der WallEWElsken van der Wall
- Paul J. van DiestPDPaul J. van Diest
- 31 December 2005
- journal article
- research article
- Published by Elsevier in Cancer Genetics and Cytogenetics
- Vol. 163 (2) , 168-172
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Differential prognostic impact of hypoxia induced and diffuse HIF-1α expression in invasive breast cancerJournal of Clinical Pathology, 2005
- Targeting HIF-1 for cancer therapyNature Reviews Cancer, 2003
- Levels of hypoxia‐inducible factor‐1α independently predict prognosis in patients with lymph node negative breast carcinomaCancer, 2003
- Human hormone-refractory prostate cancers can harbor mutations in the O 2 -dependent degradation domain of hypoxia inducible factor-1α (HIF-1α)Journal of Cancer Research and Clinical Oncology, 2002
- Carboxyl-Terminal Transactivation Activity of Hypoxia-Inducible Factor 1α Is Governed by a von Hippel-Lindau Protein-Independent, Hydroxylation-Regulated Association with p300/CBPMolecular and Cellular Biology, 2002
- The pVHL-associated SCF ubiquitin ligase complex: Molecular genetic analysis of elongin B and C, Rbx1 and HIF-1α in renal cell carcinomaOncogene, 2001
- Amplification of hypoxia-inducible factor 1α gene in prostate cancerCancer Genetics and Cytogenetics, 2001
- Mechanism of regulation of the hypoxia‐inducible factor‐1α by the von Hippel‐Lindau tumor suppressor proteinThe EMBO Journal, 2000
- Activation of Hypoxia-inducible Transcription Factor Depends Primarily upon Redox-sensitive Stabilization of Its α SubunitJournal of Biological Chemistry, 1996
- Purification and Characterization of Hypoxia-inducible Factor 1Journal of Biological Chemistry, 1995